This data strongly imply that circ-SMARCA5 is an upstream regulator of the ratio of pro- to anti-angiogenic VEGFA isoforms in GBM cells and a highly potential prognostic and anti-angiogenic molecule in GBM [115] (Figure 5 and Table 3). This evidence concerns the gene SMARCA5 and glioblastoma.